Lower contrast agent dose feasible in 320 row CT angiography

October 1, 2011

The analysis of 180 CT angiography studies done using a 320 detector row CT scanner found that a contrast media protocol based on 60 milliliters of iopamidol "had sufficient enhancement in more than 96% of coronary segments," said Frank Rybicki, MD, of Brigham and Women's Hospital in Boston, and one of the authors of the study.

"Many centers currently use a higher iodine load comparable or equal to 80 milliliters of iopamidol," he said. The study shows that "this is not necessary, and the extra contrast means unnecessary costs and increased risk of contrast-induced nephropathy (CIN) to the patients." The risk of CIN is of special concern for these patients because they commonly have a renal insufficiency, which is known major risk factor for CIN, Dr. Rybicki added.

"We analyzed larger patients only (those with a of more than 30) and found that 92% of coronary segments had sufficient enhancement," said Dr. Rybicki. "These results support the general use of 60 milliliters of iopamidol for done on 320 detector row CT scanners," he said.

The study is published in the October, 2011 .

Explore further: CT angiography improves detection of heart disease in African-Americans

Related Stories

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.